Postsecondary Education & Healthcare Workforce Development
Strategic Profile
Adtalem serves over 97,000 students and is supported by approximately 365,000 alumni and over 10,000 dedicated employees. The company's unified commitment includes documenting America's healthcare workforce crisis through rigorous research, expanding capacity to address it, and investing in long-term sustainability of the healthcare talent pipeline.
Cyborg Score Rationale
The company reported ninth consecutive quarter of enrollment growth at 8% year-over-year to 97,000 students, with revenue growing nearly 11% to $462 million. Adtalem maintains a strong financial position with trailing 12-month free cash flow of $319 million and cash equivalents of $265 million. The board authorized a new $750 million share repurchase program, underscoring management conviction in strategic direction and strong financial position.
Top Insights
Company rebranding to Covista with stock ticker change to CVSA on NYSE effective February 24, 2026, marking strategic transformation to healthcare focus
Tenth consecutive quarter of enrollment growth with 6%+ increase to 97,000 students and 12% revenue growth to $503 million in Q2 FY2026
Walden University achieved record total enrollments of 52,400 students with 13% increase in Q2, demonstrating strong digital learning platform performance
Company partnering with Google Cloud to co-develop comprehensive AI credentials program specifically for healthcare students and practicing clinicians
Named Competitors
Medical Education Programs — Traditional university offering online healthcare and medical education
Healthcare Professional Training — For-profit institution offering healthcare career programs
Online Nursing Programs — Public university providing distance nursing education
Recent Developments
(February 2026) Announced rebranding to Covista with NYSE ticker change to CVSA effective February 24, 2026
(January 2026) Reported Q2 FY2026 results with 12% revenue growth to $503 million and raised adjusted EPS guidance to 17-20% growth
(December 2025) Completed $150 million share repurchase program and authorized new $750 million repurchase authorization through December 2028
(October 2025) Posted Q1 FY2026 results with 10.8% revenue growth and 35.7% adjusted EPS growth, marking ninth consecutive quarter of enrollment growth
Open the full interactive Adtalem Global Education Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.